ProteaDX, Inc.
Palo Alto, CA, US· latest recorded location
ProteaDX, Inc. is named on 1 US grants and 3 published applications in this corpus. Its most frequent classification is A61B (Medical diagnosis and surgery).
- Granted patents
- 1
- Published applications
- 3
- Inventors
- 2
- Granted in 2026 so far
- 0
- Most recent grant
- 18 Jun 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
By publication year.
Technology areas
Share of 4 documents
Recent patents
- Transdermal sensing of analytes in interstitial fluid and associated data transmission systems8 Dec 2022US 2022/0386904 A1
- Transdermal sensing of analytes in interstitial fluid and associated data transmission systems16 Jan 2020US 2020/0015718 A1
- Apparatus and methods for transdermal and cell interstitial body fluid examination, sensing of analytes, biomarkers and drug concentrations and associated data transmission systems3 Mar 2016US 2016/0058342 A1
Most cited
By later US patents